| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |